Objective Adverse Drug Reactions (ADRs) are a major cause of patient morbidity and mortality. Spontaneous reporting of ADRs remains the cornerstone of pharmacovigilance and is important in maintaining patient safety. In order to determine whether our pharmacovigilance system could be improved, and identify reasons for under-reporting, a study to investigate the role of pharmacists in ADR reporting was performed in Shiraz. Setting: The pharmacies in Shiraz, capital of Fars province in Iran. Methods A questionnaire was prepared to investigate knowledge and attitude of pharmacists regarding ADR reporting. The questionnaire was given to 200 pharmacists who participated in a pharmacist association meeting. Main outcomes measured: The knowledge of pharmacovigilance practice, reasons for not reporting ADR, and perceptions of the Iranian pharmacists on pharmacovigilance practice were evaluated Results The response rate was 55% (n = 110). 29% of the respondents were not aware of the Iranian Pharmacovigilance Center. More than half of those responding felt that ADR reporting should be voluntary, while 26% felt it was a professional obligation. As for the purposes of ADR reporting scheme, 60% of the pharmacists falsely believed that monitoring ADR spontaneous reports aims at measuring the incidence of ADR. 42% of the pharmacists indicated that they have suspected an ADR without reporting it. Doubt about causality was the major reason for not reporting an ADR. Although our ADR center states that all suspected reactions to any drug on the market must be reported, only 17% of the respondents seemed to be aware of this responsibility. Conclusion Our pharmacists have little knowledge regarding the operation, purposes, and usefulness of ADR spontaneous reporting system. However, education and training will be important in maintaining and increasing ADR reports from pharmacists.
Knowlege Attitude Perception Pharmacist Adverse drug reaction Pharmacovigilance Iran
This is a preview of subscription content, log in to check access.
The authors thank Dr. Hashem Montaseri, Vice Chancellor for Food and Drug Organization, Shiraz University of Medical Sciences, for his support.
Conflict of interest
Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. BMJ. 1998;316:1295–8.PubMedGoogle Scholar
Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-Cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997;6(3):S71–7. doi:10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.PubMedCrossRefGoogle Scholar
Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In: Strom BL, editor. Pharmacoepidemiology. Chichester: John Wiley & Sons Ltd; 1994. p. 139–55.Google Scholar
Ramezani Tehrani B, Javid Nikoo N. Report of the Iranian Pharmacovigilance Center. Razi J. 2007;12:85–90. Article in Persian.Google Scholar
Bateman DN, Sanders GLS, Rawling MD. Attitudes to adverse drug reaction reporting in the northern region. Br J Clin Pharmacol. 1992;34:421–6.PubMedGoogle Scholar
Belton K. The European Pharmacovigilance Research Group. attitude survey of adverse drug reaction reporting by healthcare professionals across the European Union. Eur J Clin Pharmacol. 1997;52:423–7. doi:10.1007/s002280050314.PubMedCrossRefGoogle Scholar
Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62. doi:10.1007/s11096-008-9209-4.CrossRefGoogle Scholar
Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists’ attitudes toward the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429–34. doi:10.1002/pds.1298.PubMedCrossRefGoogle Scholar
Walker SR, Lumley CE. The attitudes of general practitioners to the monitoring and reporting of adverse drug reactions. Pharm Med. 1986;1:195–203.Google Scholar
Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986;1:205–12.Google Scholar
Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood S. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223–6.PubMedGoogle Scholar